Certain aspects of intensive care unit admission and care, including patient acuity and treatments to manage acute critical illnesses, can intensify loss of functionality and decrease quality of life after hospital discharge. We sought to identify the risk factors associated with functional decline following critical illness and explore its impact on health-related quality of life in a post hoc analysis of a prospective multi-center cohort study. The study involved 1,301 critically ill subjects who were assessed 3 months after their discharge from the ICU.
View Article and Find Full Text PDFBackground: Small bowel Crohn's disease (SBCD) is increasingly treated with biological therapies. Predicting response or remission (RoR) for individual patients is difficult and complicates treatment strategy. We aimed to determine if motility magnetic resonance imaging (mMRI) is superior to CRP and fecal calprotectin (FC) for the prediction of RoR at 1 year in patients commencing biologics for SBCD.
View Article and Find Full Text PDFBackground: Chronic knee pain from osteoarthritis (OA) affects a significant proportion of adults over 40. Total knee arthroplasty (TKA) remains the standard for advanced OA, yet up to 20% of patients experience chronic postsurgical pain (CPSP). Genicular nerve radiofrequency ablation (GNRFA) can alleviate pain in those unresponsive to conservative treatments or TKA.
View Article and Find Full Text PDFTuberculosis (TB) is a serious public health concern in many regions of the world and the only approved vaccine to prevent TB is the live-attenuated BCG vaccine. Despite being widely used, the BCG vaccine fails to prevent pulmonary TB in adults. The BCG vaccine is administered during the neonatal period when levels of the immunosuppressive cytokine interleukin (IL)-27 are elevated, and previous studies have demonstrated that the source of IL-27 can impact downstream immune responses.
View Article and Find Full Text PDFPurpose Of Review: Methadone is a synthetic opioid extensively used in opioid use disorder management but is gaining recognition for its unique pharmacological properties that make it a viable alternative for chronic pain management. This review aims to explore methadone's pharmacokinetics, pharmacodynamics, efficacy, and safety profile to assess its potential role in managing chronic pain conditions.
Recent Findings: Methadone's dual action as a mu-opioid receptor agonist and NMDA receptor antagonist positions it as an effective option for managing both nociceptive and neuropathic pain.